Search research articles
Contact Us
Filters
Showing results (1-10 of 295) with videos related to
Page
of 30
Sort By:
World Journal of Hepatology
|
December 17, 2010
Combination treatment in HBeAg-negative chronic hepatitis B
Konstantinos Tziomalos
Current Pharmaceutical Design
|
February 4, 2017
The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia
Konstantinos Tziomalos
Current Hypertension Reviews
|
May 1, 2019
Secondary Hypertension: Novel Insights
Konstantinos Tziomalos
Panminerva Medica
|
April 2, 2016
Unresolved issues in lipid-lowering treatment
Konstantinos Tziomalos
Current Pharmaceutical Design
|
August 12, 2016
Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome
Konstantinos Tziomalos
World Journal of Hepatology
|
December 17, 2010
Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
Konstantinos Tziomalos
World Journal of Hepatology
|
October 29, 2014
Lipid-lowering agents in the management of nonalcoholic fatty liver disease
Konstantinos Tziomalos
Frontiers in Endocrinology
|
October 24, 2022
Adiponectin: A player in the pathogenesis of hormone-dependent cancers
Alexandra Tsankof, Konstantinos Tziomalos
Current Hypertension Reviews
|
May 9, 2018
Should all Hypertensive Patients be Screened for Primary Aldosteronism?
Stelina Alkagiet, Konstantinos Tziomalos
Expert Opinion on Investigational Drugs
|
February 13, 2019
Experimental therapies targeting apolipoprotein C-III for the treatment of hyperlipidemia - spotlight on volanesorsen
Dimitrios Milonas, Konstantinos Tziomalos
Page
of 30
Search research articles
Search
Showing results (1-10 of 295) with videos related to
Sort By:
Page
of 30
World Journal of Hepatology
|
December 17, 2010
Combination treatment in HBeAg-negative chronic hepatitis B
Konstantinos Tziomalos
Current Pharmaceutical Design
|
February 4, 2017
The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia
Konstantinos Tziomalos
Current Hypertension Reviews
|
May 1, 2019
Secondary Hypertension: Novel Insights
Konstantinos Tziomalos
Panminerva Medica
|
April 2, 2016
Unresolved issues in lipid-lowering treatment
Konstantinos Tziomalos
Current Pharmaceutical Design
|
August 12, 2016
Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome
Konstantinos Tziomalos
World Journal of Hepatology
|
December 17, 2010
Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
Konstantinos Tziomalos
World Journal of Hepatology
|
October 29, 2014
Lipid-lowering agents in the management of nonalcoholic fatty liver disease
Konstantinos Tziomalos
Frontiers in Endocrinology
|
October 24, 2022
Adiponectin: A player in the pathogenesis of hormone-dependent cancers
Alexandra Tsankof, Konstantinos Tziomalos
Current Hypertension Reviews
|
May 9, 2018
Should all Hypertensive Patients be Screened for Primary Aldosteronism?
Stelina Alkagiet, Konstantinos Tziomalos
Expert Opinion on Investigational Drugs
|
February 13, 2019
Experimental therapies targeting apolipoprotein C-III for the treatment of hyperlipidemia - spotlight on volanesorsen
Dimitrios Milonas, Konstantinos Tziomalos
Page
of 30